nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Asciminib: First Approval
|
Deeks, Emma D. |
|
|
82 |
2 |
p. 219-226 |
artikel |
2 |
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy
|
Roeker, Lindsey E. |
|
|
82 |
2 |
p. 133-143 |
artikel |
3 |
Envafolimab: First Approval
|
Markham, Anthony |
|
|
82 |
2 |
p. 235-240 |
artikel |
4 |
Gastrointestinal Dysfunction in Parkinson’s Disease
|
Safarpour, Delaram |
|
|
82 |
2 |
p. 169-197 |
artikel |
5 |
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
|
Evans, Marc |
|
|
82 |
2 |
p. 97-108 |
artikel |
6 |
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
|
Rojas-Rivera, Jorge |
|
|
82 |
2 |
p. 109-132 |
artikel |
7 |
Somatrogon: First Approval
|
Lamb, Yvette N. |
|
|
82 |
2 |
p. 227-234 |
artikel |
8 |
Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis
|
Lattanzi, Simona |
|
|
82 |
2 |
p. 199-218 |
artikel |
9 |
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets
|
Dang, Deanna H. |
|
|
82 |
2 |
p. 145-167 |
artikel |